Search Results - "Hwang, Injeoung"
-
1
Novel 2,6,9-Trisubstituted Purines as Potent CDK Inhibitors Alleviating Trastuzumab-Resistance of HER2-Positive Breast Cancers
Published in Pharmaceuticals (Basel, Switzerland) (23-08-2022)“…HER2-positive (HER2+) breast cancer is defined by HER2 oncogene amplification on chromosome 17q12 and accounts for 15−20% population of breast-cancer patients…”
Get full text
Journal Article -
2
Identification of a novel potent CDK inhibitor degrading cyclinK with a superb activity to reverse trastuzumab-resistance in HER2-positive breast cancer in vivo
Published in European journal of medicinal chemistry (15-01-2024)“…CDK12 is overexpressed in HER2-positive breast cancers and promotes tumorigenesis and trastuzumab resistance. Thus CDK12 is a good therapeutic target for the…”
Get full text
Journal Article -
3
Identification of novel class inhibitors of NSD3 methyltransferase showing a unique, bivalent binding mode in the SET domain
Published in Chemical biology & drug design (01-09-2023)“…NSD3/WHSC1L1 lysine methyltransferase promotes the transcription of target genes through di‐ or tri‐methylation at histone H3K36 using SAM as a cofactor…”
Get full text
Journal Article -
4
Discovery of N-benzylbenzamide-based allosteric inhibitors of Aurora kinase A
Published in Bioorganic & medicinal chemistry (15-03-2024)“…[Display omitted] •Novel AurkA allosteric inhibitors of N-benzylbenzamide backbone were designed and synthesized.•The most potent analogue 6h (AurkA…”
Get full text
Journal Article